0001493152-26-000797.txt : 20260107 0001493152-26-000797.hdr.sgml : 20260107 20260107160539 ACCESSION NUMBER: 0001493152-26-000797 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260107 DATE AS OF CHANGE: 20260107 EFFECTIVENESS DATE: 20260107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dermata Therapeutics, Inc. CENTRAL INDEX KEY: 0001853816 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-569228 FILM NUMBER: 26515742 BUSINESS ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS RD., #322 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858)-223-0882 MAIL ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS RD., #322 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001853816 Dermata Therapeutics, Inc. 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 858-223-0882 DELAWARE None None Corporation true 2021 Gerald Proehl 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Director Kyri K. Van Hoose 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Christopher J. Nardo 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Maria Bedoya Toro Munera 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Executive Officer David Hale 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Director Wendell Wierenga 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Director Andrew Sandler 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Director Brittany Bradrick 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Director Kathleen Scott 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Director Mary Fisher 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Director Steven J. Mento 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b false 2025-12-29 false true true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue 4th Floor New York NY NEW YORK 10022 All States false 4124591 4124591 0 false 14 342500 true 0 Includes a cash fee of 7% of gross proceeds from outside investors and 3.5% from inside investors, 1% management fee, $25,000 non-accountable expense allowance, and $40,000 accountable expense allowance. 0 true Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3. false Dermata Therapeutics, Inc. /s/ Gerald Proehl Gerald Proehl Chief Executive Officer 2026-01-05